Skip to content

Clinical trials

Phase 3 Leiomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Phase: Phase 3 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20111
20151
20171
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Advenchen Laboratories, LLC1
Alliance for Clinical Trials in Oncology1
Children's Oncology Group1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Janssen Research & Development, LLC1
PharmaMar1
Polaris Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma8
Sarcoma5
Liposarcoma4
Histiocytoma, Malignant Fibrous3
Sarcoma, Alveolar Soft Part3
Sarcoma, Synovial3
Fibrosarcoma2
Hemangiosarcoma2
Neurofibrosarcoma2
Dermatofibrosarcoma1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.